Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
Open Access
- 15 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5), e36713
- https://doi.org/10.1371/journal.pone.0036713
Abstract
The fibroblast growth factor (FGF)-FGF receptor (FGFR) signaling system plays critical roles in a variety of normal developmental and physiological processes. It is also well documented that dysregulation of FGF-FGFR signaling may have important roles in tumor development and progression. The FGFR4–FGF19 signaling axis has been implicated in the development of hepatocellular carcinomas (HCCs) in mice, and potentially in humans. In this study, we demonstrate that FGFR4 is required for hepatocarcinogenesis; the progeny of FGF19 transgenic mice, which have previously been shown to develop HCCs, bred with FGFR4 knockout mice fail to develop liver tumors. To further test the importance of FGFR4 in HCC, we developed a blocking anti-FGFR4 monoclonal antibody (LD1). LD1 inhibited: 1) FGF1 and FGF19 binding to FGFR4, 2) FGFR4–mediated signaling, colony formation, and proliferation in vitro, and 3) tumor growth in a preclinical model of liver cancer in vivo. Finally, we show that FGFR4 expression is elevated in several types of cancer, including liver cancer, as compared to normal tissues. These findings suggest a modulatory role for FGFR4 in the development and progression of hepatocellular carcinoma and that FGFR4 may be an important and novel therapeutic target in treating this disease.This publication has 34 references indexed in Scilit:
- Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-RegulationClinical Cancer Research, 2009
- Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesisMolecular Carcinogenesis, 2008
- Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating β-Catenin SignalingCancer Research, 2008
- Co-receptor Requirements for Fibroblast Growth Factor-19 SignalingOnline Journal of Public Health Informatics, 2007
- Liver-specific Activities of FGF19 Require Klotho betaOnline Journal of Public Health Informatics, 2007
- Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21Journal of Biological Chemistry, 2007
- Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma modelsOncogene, 2007
- Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR DimerizationMolecular and Cellular Biology, 2005
- Fibroblast growth factors in cancer: therapeutic possibilitiesEmerging Therapeutic Targets, 2002
- A Mouse Model of Hepatocellular Carcinoma: Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic MiceThe American Journal of Pathology, 2002